Fundraising FoxOrbiMed — 2016 Investments
9 investments dated 2016 · listed companies and verified rows first · show all
Prelude Therapeutics is a precision oncology company developing cancer treatments for areas of high unmet need, with a pipeline including selective KAT6A degraders and mutant-selective JAK2V617F JH2 inhibitors.
BiotechHealthtechNewark, US
Krishna Vaddi(Executive Officer, Director)
BoardPaul Friedman(Director of Issuer)
Board seatDavid Bonita· per SEC Form D
Co-investorsThe Innovation Space
SI-BONE develops medical devices for treating sacroiliac (SI) joint dysfunction and chronic low back pain, targeting patients and physicians.
HealthtechMedical DevicesSan Jose, US
Mark Reiley(Director)inJeffrey W. Dunn(Executive Officer, Director)Robert E. Johnson(Executive Officer)Dan Murray(Executive Officer)Laura A. Francis(Chief Executive Officer)
BoardTimothy E. Davis(Director)
Board seatDavid Bonita· per SEC Form D · $21M raise · filed Jun 2016
Co-investorsArboretum VenturesMontreux Equity Partners
BiotechCincinnati, US
Robert Shalwitz(Executive Officer)Joseph Gardner(Founder)inDuane Nash(Director)Kevin Peters(Executive Officer)Steve Pakola(Executive Officer)Ian A.W. Howes(Executive Officer)
Board seatChau Khuong· per SEC Form D
Co-investorsCincyTechSofinnova VenturesAlly Bridge Group
Precision medicine company developing therapeutics for genetically-defined age-related macular degeneration.
BiotechCambridge, US
James McLaughlin(Executive Officer, Director)in
BoardJean George(Director)Jason Rhodes(Director)in
Board seatCarl Gordon· per SEC Form D
Co-investorsAltium CapitalLightstone VenturesAtlas Venture
Inspire Medical Systems develops an FDA-approved implantable device that treats obstructive sleep apnea (OSA) by working with the patient's natural breathing, controlled via a small remote and intended for patients for whom CPAP is not effective.
Digital HealthHealthtechMedical DevicesGolden Valley, US
Tim Herbert(Founder)in
BoardMudit Jain(Director)Joyce Erony(Director)inDana Mead(Director)Casey Tansey(Director)
Board seatChau Khuong· per SEC Form D · $37.5M raise · filed Nov 2016
Co-investorsAmzak HealthAPERTURE Venture PartnersUS Venture Partners
BiotechBoston, US
Darlene Deptula-Hicks(Executive Officer)inStephen S. Yoder(Executive Officer, Director)inDarlene M. Deptula-Hicks(Acting Chief Financial Officer)in
BoardChristina Takke(Director)Steven Prelack(Director)
Board seatChau Khuong· per SEC Form D · $16.5M raise · filed Jun 2016
Co-investorsRidgeback CapitalBiotechnology Value FundFrazier Life Sciences
BiotechSouth San Francisco, US
Gerrit Klaerner(Executive Officer, Director)Melissa Miksch(Executive Officer)
BoardSandra Coufal(Director)Robert Alpern(Director)
Board seatKlaus VeitingerDavid Bonita· per SEC Form D
Co-investorsAvoro Capital AdvisorsLongitude CapitalWellington ManagementFrazier Life SciencesHercules Capital, Inc.
Augmedix builds AI-driven documentation technology for clinicians, aiming to reduce time spent on technology so providers can focus on patient care.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Ian Shakil(Executive Officer, Director)inPelu Tran(Cofounder)inEmmanuel Krakaris(Executive Officer, Director)inPaul Ginocchio(Executive Officer)inSandra Breber(Executive Officer)inJoseph Marks(Director)
Co-investorsDCM VenturesEvolution VC PartnersGaingelsGreat Oaks Venture CapitalLifeSci Venture PartnersOVO Fund+4 more
__Twitter.png)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.